🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lakewood-Amedex Biotherapeutics, Inc. (LABT)
NASDAQ: LABT · Real-Time Price · USD
0.2810
+0.0681 (31.99%)
Nov 20, 2026, 10:12 AM EST - Market open

LABT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.02-0.840.670.13
Net Debt / Equity Ratio
-1.11-0.72-1.00-1.27
Net Debt / EBITDA Ratio
0.47-0.380.100.67
Net Debt / FCF Ratio
0.79-0.730.070.85
Quick Ratio
4.940.101.363.10
Current Ratio
5.220.131.553.14
Return on Equity (ROE)
-833.72%--195.47%-
Return on Assets (ROA)
-350.75%-753.50%-172.15%-120.13%
Return on Capital Employed (ROCE)
-235.90%196.10%-706.50%-178.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-87.70%-0.78%-1.44%-
SEC Filings: 10-K · 10-Q